投资界发布2020Venture50初评晋级名单，恒旭资本投资企业德美医疗、高诚生物、亚虹医药、瑞博生物、震坤行获选风云榜_Updates_News

投资界发布2020Venture50初评晋级名单，恒旭资本投资企业德美医疗、高诚生物、亚虹医药、瑞博生物、震坤行获选风云榜

2020-11-20

近日，投资界发布2020Venture50初评晋级名单，恒旭资本投资企业德美医疗、高诚生物、亚虹医药、瑞博生物、震坤行获选风云榜。

2020年对创新企业来说可谓是一场“华丽冒险”：一方面，防疫常态化背景下，我国经济结构逐步优化，但市场环境仍充满不确定性；另一方面新一轮科技革命和产业变革深入发展，科技迭代、产业赋能不断，新模式与新商业在变化与变革中诞生……

此次Venture50评选贯穿2020全年，持续释放创业活力，继续延续往届风云榜与新芽榜TOP50双榜设置。其中，风云榜评选企业为融资阶段在B轮以后的未上市企业，而新芽榜的评选企业为融资阶段在B轮及其以前、创立时间在3年以内的未上市企业。此外，还特邀超百位投资人从多个资本维度进行评选。经评委们审慎评分，在5000余家企业中甄选出350家企业项目进入初评榜单。

Address：5th Floor, Building N3, New Bund Square City, No. 2, Lane 131, Qiantan Avenue, Pudong New District, Shanghai

Email：scir@hengxucapital.com

Change of Address Notice

Dear investors and partners,

With your ongoing care and support, Hengxu Capital has achieved significant development and progress since its establishment. In order to better meet the needs of our business operations, our office location will be relocated to 5F, Building N3, New Bund Square City, No. 2, Lane 131, Qiantan Avenue, Pudong New District, Shanghai(Map Link: https://j.map.baidu.com/b5/x7VK).

The new office space is conveniently located with excellent facilities, providing improved conditions for meetings, receptions, and work. This relocation will facilitate better communication and collaboration between Hengxu Capital and our partners, enhancing employee satisfaction and office efficiency, and laying a solid foundation for continued and rapid business development.

The new office has been officially in use since January 29, and our mailing address has been switched to the new location. Considering the approaching Chinese New Year, we will not hold a relocation ceremony at the moment but plan to invite you to visit and guide us at a suitable time in the future.

If you have any questions or concerns, please feel free to contact us. Our phone numbers and email addresses remain unchanged. Once again, we appreciate your support and understanding, and we look forward to creating a brighter future together.

Shanghai SAIC Hengxu Capital Co., Ltd.

Jan. 29, 2024